Drug Discovery Chemistry Europe 2026

Drug Discovery Chemistry Europe 2026 will take place from 10 to 12 November 2026 at the InterContinental Barcelona. Organised by Cambridge Healthtech Institute (CHI), the conference will bring together professionals from the pharmaceutical and biotechnology industries, researchers and experts in medicinal chemistry, biology and computational sciences to share new strategies, technologies and approaches to drug discovery and optimisation.

The event will combine scientific content, real-world applications and networking opportunities, with a particular focus on the new tools transforming the different stages of the drug discovery process.

The programme is structured around four main areas:

• Lead Generation Strategies: new approaches to candidate identification and selection, from DNA-encoded libraries and fragment screening to virtual libraries and AI-powered tools.
• AI/ML for Drug Discovery: practical applications of artificial intelligence and machine learning in the discovery of new targets and molecules.
• Next-Gen Degraders: Glues & Conjugates: advances in targeted protein degradation, PROTACs, molecular glues and novel conjugates.
• Targeting PPIs with Peptides & Small Molecules: new strategies to address protein-protein interactions using small molecules, peptides, biophysics and AI tools.

The conference will also feature plenary sessions, scientific presentations, poster sessions and networking opportunities to foster knowledge exchange and collaboration between industry and academia.

Companies and organisations from the BioRegion of Catalonia can benefit from a 25% discount on registration for Drug Discovery Chemistry Europe 2026 by using the code biocat25 when registering.